J Periodontal Implant Sci.  2013 Aug;43(4):177-182. 10.5051/jpis.2013.43.4.177.

Efficacy of nonsurgical periodontal therapy on glycaemic control in type II diabetic patients: a randomized controlled clinical trial

• Telgi RL
• Tandon V
• Tangade PS
• Tirth A
• Kumar S
• Yadav V

• KMID: 2027813
• DOI: http://doi.org/10.5051/jpis.2013.43.4.177

Abstract

PURPOSE
Diabetes and periodontal disease are two common diseases with high prevalence rates. Recent evidence has shown a bidirectional relationship between diabetes and periodontitis. The aim of this study was to investigate the effects of nonsurgical periodontal therapy on glycemic control in type 2 diabetes mellitus patients.
METHODS
Sixty subjects aged 35-45 years with blood sugar controlled by oral hypoglycaemic agents were randomly divided equally among 3 groups: group A (scaling, mouthwash, and brushing), group B (mouthwash and brushing), and group C (brushing only). Glycated haemoglobin (HbA1c), fasting blood sugar (FBS), probing pocket depth (PPD), gingival index (GI), plaque index (PI), and the relevant drug history were recorded at baseline and after 3 months of intervention. Comparison of the mean difference among the variables was performed by parametric and nonparametric tests, which were further evaluated using multiple regression analysis.
RESULTS
The mean differences between the PPD, FBS, HbA1c, GI, and PI in groups A and B were found to be statistically significant (P<0.001). Multiple regression analysis in group A showed that out of all the independent variables, GI and frequency of drug administration independently (b=0.3761 and b=0.598) showed a significantly greater impact on HbA1c (R2=0.832, P<0.05).
CONCLUSIONS
Nonsurgical periodontal therapy can effectively decrease HbA1c levels in type 2 diabetes mellitus patients on medication.

Keyword

Glycosylated hemoglobin A; Periodontal debridement; Type II diabetes mellitus

MeSH Terms

Aged
Blood Glucose
Diabetes Mellitus, Type 2
Fasting
Hemoglobin A, Glycosylated
Humans
Periodontal Debridement
Periodontal Diseases
Periodontal Index
Periodontitis
Prevalence
Tuberculin
Blood Glucose
Hemoglobin A, Glycosylated
Tuberculin

Reference

1. Mealy B. Diabetes Mellitus. In : Greenberg MS, Glick M, editors. Burket's oral medicine diagnosis and treatment. 10th ed. New York: B.C. Decker;2003. p. 563–577.

2. Taylor GW. The effects of periodontal treatment on diabetes. J Am Dent Assoc. 2003; 134 Spec No:41S–48S.

3. Chinese Diabetes Society. China guideline for type 2 diabetes. Chin J Diabetes Mellitus. 2010; 2:Suppl 2. 6–56.

4. Seppälä B, Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol. 1994; 21:161–165.

5. Tervonen T, Knuuttila M. Relation of diabetes control to periodontal pocketing and alveolar bone level. Oral Surg Oral Med Oral Pathol. 1986; 61:346–349.

6. Southerland JH, Taylor GW, Offenbacher S. Diabetes and periodontal infection: making the connection. Clin Diabetes. 2005; 23:171–178.

7. Dağ A, Firat ET, Arikan S, Kadiroglu AK, Kaplan A. The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients. Aust Dent J. 2009; 54:17–22.

8. Mealey BL. Periodontal disease and diabetes: a two-way street. J Am Dent Assoc. 2006; 137:26S–31S.

9. Loe H, Silness J. Periodontal disease in pregnancy: I. prevalence and severity. Acta Odontol Scand. 1963; 21:533–551.

10. Silness J, Loe H. Periodontal disease in pregnancy: II. correlation between oral hygiene and periodontal condtion. Acta Odontol Scand. 1964; 22:121–135.

11. Cohen DW, Friedman LA, Shapiro J, Kyle GC, Franklin S. Diabetes mellitus and periodontal disease: two-year longitudinal observations. I. J Periodontol. 1970; 41:709–712.

12. Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol. 2001; 6:1–8.

13. Moeintaghavi A, Arab HR, Bozorgnia Y, Kianoush K, Alizadeh M. Non-surgical periodontal therapy affects metabolic control in diabetics: a randomized controlled clinical trial. Aust Dent J. 2012; 57:31–37.

14. Lowenguth RA, Greenstein G. Clinical and microbiological response to nonsurgical mechanical periodontal therapy. Periodontol 2000. 1995; 9:14–22.

15. da Cruz GA, de Toledo S, Sallum EA, Sallum AW, Ambrosano GM, de Cassia Orlandi Sardi J, et al. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus. J Periodontol. 2008; 79:1150–1157.

16. Tervonen T, Karjalainen K, Knuuttila M, Huumonen S. Alveolar bone loss in type 1 diabetic subjects. J Clin Periodontol. 2000; 27:567–571.

17. Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol. 2000; 27:537–541.

18. Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care. 2010; 33:421–427.

19. Svenson KL, Lundqvist G, Wide L, Hallgren R. Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Metabolism. 1987; 36:940–943.

20. Beck-Nielsen H. Clinical Disorders of Insulin Resistance. In : Alberti KG, Viberti G, editors. International textbook of diabetes mellitus. New York: Wiley;1992. p. 531–568.

21. Sammalkorpi K. Glucose intolerance in acute infections. J Intern Med. 1989; 225:15–19.

22. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol. 1998; 3:51–61.

23. Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol. 2001; 72:774–778.

24. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992; 41:Suppl 2. 97–101.

25. Ling PR, Istfan NW, Colon E, Bistrian BR. Differential effects of interleukin-1 receptor antagonist in cytokine- and endotoxin-treated rats. Am J Physiol. 1995; 268(2 Pt 1):E255–E261.

26. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics: results after 5 years. J Clin Periodontol. 1996; 23:92–100.

27. Alpagot T, Wolff LF, Smith QT, Tran SD. Risk indicators for periodontal disease in a racially diverse urban population. J Clin Periodontol. 1996; 23:982–988.

28. Kiran M, Arpak N, Unsal E, Erdogan MF. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol. 2005; 32:266–272.